Tag: Infections
Shoolini University scientist unlocks pharmacological power of himalayan plants for modern...
Dr Radha’s pioneering research validates traditional remedies against respiratory diseases, infections, and antimicrobial resistance, leading to new patents and eco-friendly formulations
Cannabis compounds show promise in killing deadly fungal infections, Macquarie University...
Fungal infections affect one billion people worldwide
IIT Guwahati harnesses clay sedimentation to identify and measure Coronavirus
Posing a threat to the human lives globally, COVID-19 pandemic revealed a critical gap in how we detect and track viral infections
Zimmer Biomet India launches bone cements by Teknimed
Tekcem® offers several key advantages, including the incorporation of gentamicin (1G) for superior bacterial defense, ensuring better efficiency against infections
CrisprBits develops PathCrisp for early detection of antibiotic resistance
This new CRISPR-based platform combats antibiotic resistance in hospital-acquired infections by delivering results within two hours, enabling faster and targeted treatment for patients
World AIDS Day: India’s sustained efforts have ensured low HIV epidemic...
Over the years with new infections in the country in 2023 almost 44% lower than in 2010 while AIDS related deaths declined by 79%
Abbott launches 14 valent Pneumococcal Conjugate Vaccine for broader protection against...
Pneumococcal vaccines help address pneumococcal bacterial infections, including pneumonia and meningitis, for which children under two years of age are most at risk
India gets its first indigenous antibiotic ‘Nafithromycin’ to combat drug resistance
New antibiotic offers 10x efficacy with just 3 doses to combat drug-resistant pneumonia
GARDP and Bugworks join forces to accelerate development of a novel...
The compound being developed by Bugworks, BWC0977, is aimed at treating patients with serious bacterial infections in both critical care and community settings
Biotech startup CrisprBits raises 250,000 USD in pre-seed round from US-based...
The company plans to extend its CRISPR-based diagnostics platform to point-of-care detection of pathogens and antimicrobial resistance genes associated with hospital-acquired infections